Boehringer Ingelheim

GlaxoSmithKline Unit Joins Patent Pool for AIDS Drugs

Boehringer Ingelheim Ohio Subsidiary Enters Consent Decree

Topics • Technology

Global Meets Local in Austria

Eli Lilly Banks on Cost Controls for Higher 2013 Profit

Drugmaker Boehringer Settles Marketing Claim for $95 Million

Maturing Belgian Biotechs Outshine European Peers

Topics • Technology

Stick to Your Strengths with Biosimilars

Topics • Technology

Thriving Generics

U.S. Medicine Spending Rose to $320 Billion Last Year

Bayer Sees Healthcare Business Driving Growth

Peter Pollak on the World of Fine Chemicals

Innovation Expected from API Manufacturers

Amylin Sues Lilly over Diabetes Partnership

Merck, Sanofi Animal Health JV to Close Later Than Expected

Novartis CEO Joe Jimenez: Animal Health Acquisition Makes Sense

Topics • Strategy

Oracle’s Agile PLM Reorganizes Pharma, From Lab to Launch

Amgen To Sell California Drug Plant To Boehringer

Eli Lilly, Boehringer Ingelheim in Drug-Development Alliance

Fresenius Could Be in the Mood for Acquisitions

Abbott to Pay $121.5 Million in False Claims Settlement

Topics • Chemistry

Live And Learn

Pfizer Selling China Swine Vaccine Unit to Harbin Pharma

Pfizer Exec Jumps Ship to Head AstraZeneca's R&D

Topics • Technology

Cost, Quality And Reliability

Bayer Still Out To Buy, Not Sell, Vet Businesses

Boehringer to Buy Rest of Japan's SSP

Drugmaker Boehringer Ingelheim Not For Sale

Boehringer, Vitae ink $242 Million Alzheimer’s Deal

Top-Feature

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Special Issue

Circular Plastics Economy

Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

LISA Life Science Austria

DCAT - Drug, Chemical & Associated Technologies Association

Thomson Reuters

CHEManager International c/o Wiley-VCH GmbH

ACIB Austrian Centre of Industrial Biotechnology

PP Consulting

JMP Statistical Discovery / SAS Institute GmbH

Boehringer Ingelheim

QUANTRO Therapeutics GmbH

Frost & Sullivan

Oracle Germany

SchüllerConsulting

BearingPoint GmbH